Increased RBP4 Isoforms in Kidney Disease
Author Information
Author(s): Simone K. Frey, Britta Nagl, Andrea Henze, Jens Raila, Beate Schlosser, Thomas Berg, Martin Tepel, Walter Zidek, Martin O. Weickert, Andreas Pfeiffer, Florian J. Schweigert
Primary Institution: Institute of Nutritional Science, University of Potsdam, Germany
Hypothesis
The study investigates whether chronic liver disease (CLD) influences the levels of retinol-binding protein 4 (RBP4) isoforms in patients with chronic kidney disease (CKD).
Conclusion
RBP4 isoforms are significantly increased in CKD patients but not in CLD patients, indicating a strong relationship between RBP4 levels and kidney function.
Supporting Evidence
- RBP4 levels were significantly elevated in CKD patients compared to controls.
- In CLD patients, RBP4 levels were lower than in controls.
- The study found no increase in RBP4 isoforms in CLD patients.
Takeaway
This study found that people with kidney disease have more of a certain protein called RBP4, while those with liver disease do not show the same increase.
Methodology
RBP4 levels and isoforms were analyzed in plasma samples from patients with CKD, CLD, and healthy controls using ELISA and mass spectrometry.
Participant Demographics
36 CKD patients, 55 CLD patients, and 50 healthy controls; no significant differences in age and BMI.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website